Conférence

Notice

Langue :

Anglais

Crédits

Université de Bordeaux - Service Audiovisuel et Multimédia (Production), Université de Bordeaux - Service Audiovisuel et Multimédia (Publication), Université de Bordeaux - Service Audiovisuel et Multimédia (Réalisation), Antoine Italiano (Intervention)

Conditions d'utilisation

Creative Commons (BY NC)

DOI : 10.60527/x30d-tm18

Citer cette ressource :

Antoine Italiano. Univ Bordeaux. (2014, 7 novembre). Multisarc , in BRIO SIRIC scientific day 2. [Vidéo]. Canal-U. https://doi.org/10.60527/x30d-tm18. (Consultée le 19 juillet 2025)

Multisarc

Réalisation : 7 novembre 2014 - Mise en ligne : 18 décembre 2014

document 1 document 2 document 3
niveau 1 niveau 2 niveau 3

Descriptif

Translational science : how to move from biology to clinical applications

Soft-tissues sarcomasrepresent an heterogeneous group of tumors. Stadard of care is surgicalresection followed by radiotherapy. Patients with metastatic relapse aretreated with chemotherapy but the overall survival is only approximatly 18months.
Actual research try to define new therapeutic targets, adapted to the type ofsarcoma.

The personalized medicineproject aims to propose to patients with advanced sarcoma a targeted therapybased on the genomic and immunilogical profile.
The main difference with other projects resides in the genomic profile, whichwill be determined with a "whole genome" analysis.

Cette présentation a été donnée dans le cadre du ScientificBRIO Day 2 organisé annuellement par le SIRIC BRIO et qui a pour but de réunirtous les acteurs du SIRIC BRIO et plus largement de la cancérologie à Bordeaux.

Intervention

Italiano

Antoine

Docteur en médecine (en 2005)

Thème

Disciplines :

Dans la même collection

Conférence

00:29:16

Favoris
Translational cancer genomics and proteomics
SLEIJFER Stefan
Translational science : how to move from biology to clinical applications Evaluation of cell-free DNA (cfDNA) is a very attractive tool to serve as “liquid biopsy” to define and establish
Cancer
Oncologie
Thérapie
Recherche
18.12.2014
document 1 document 2 document 3
niveau 1 niveau 2 niveau 3
Conférence

00:13:01

Favoris
BRIO's facts and figures, structuration projects : Axe Cancer, translational research centerUpdate …
SOUBEYRAN Pierre
Update the implementation of BRIO Brio organisation is now fully up and running, and more than 100 research projects are currently active into the 6 integrated research programmes. In addition,
Cancer
Oncologie
Thérapie
Recherche
18.12.2014
document 1 document 2 document 3
niveau 1 niveau 2 niveau 3
Conférence

00:15:00

Favoris
Standardizing G8 evaluation
SOUBEYRAN Pierre
Non-pharmaceutical innovations and public health Management of the frail elderly with cancer is a challenge. Beside a poor outcome as compared to younger subjects, physicians will face increased
Cancer
Oncologie
Thérapie
Recherche
18.12.2014
document 1 document 2 document 3
niveau 1 niveau 2 niveau 3
Conférence

00:16:54

Favoris
Bordeaux Cancer Initiative
DESSIS Damien

ELUSTONDO Frédéric
Translational science : how to move from biology to clinical applications Upon request of the University, the SIRIC was mandated to develop a transversal cancer axis at the University. The axis
Cancer
Oncologie
Thérapie
Recherche
18.12.2014
document 1 document 2 document 3
niveau 1 niveau 2 niveau 3
Conférence

00:18:28

Favoris
Sociology contribution to understanding the (no)diffusion of a medical innovation
GORRY Philippe
Interface technology/clinical/SHS/public health : case study interventional radiology We will present results of an undergoing study on the socioeconomic processes of recognition in oncology of a
Cancer
Oncologie
Thérapie
Recherche
18.12.2014
document 1 document 2 document 3
niveau 1 niveau 2 niveau 3
Conférence

01:00:29

Favoris
Expert panel discussions : why translational research matters
CAMERON David
En point d'orgue du Scientific BRIO Day, David Cameron, spécialiste reconnu en Oncologie, Professeur à l'Université d'Edimbourg, anime un débat sur la question de la recherche dite translationnelle,
Cancer
Oncologie
Thérapie
Recherche
18.12.2014
document 1 document 2 document 3
niveau 1 niveau 2 niveau 3
Conférence

00:09:10

Favoris
Innovation reimbursement
FILLATREAU Christian
Interface technology/clinical/SHS/public health : case study interventional radiology Novel diagnostic and therapeutic strategies is a continuum of 3 strongly associated phases : clinical
Cancer
Oncologie
Thérapie
Recherche
18.12.2014
document 1 document 2 document 3
niveau 1 niveau 2 niveau 3
Conférence

00:18:23

Favoris
A new preclinical model to test the response of breast cancer to genomically targeted therapy
IGGO Richard
Translational science : how to move from biology to clinical applications The rapid progress in next generation DNA sequencing technology (NGS) means it is now possible, in principle, to obtain a
Cancer
Oncologie
Therapie
Recherche
18.12.2014
document 1 document 2 document 3
niveau 1 niveau 2 niveau 3
Conférence

00:22:10

Favoris
Technique, research and benefits
GRENIER Nicolas

PALUSSIèRE Jean
Interface technology/clinical/SHS/public health : case study interventional radiology
Cancer
Oncologie
Thérapie
Recherche
18.12.2014
document 1 document 2 document 3
niveau 1 niveau 2 niveau 3
Conférence

00:19:52

Favoris
Curing leukemia ?
MAHON François-Xavier
Non-pharmaceutical medical innovations and public health The use of tyrosine kinase inhibitors (TKIs) targeted against the BCR-ABL1 oncoprotein has proven remarkably successful in chronic myeloid
Cancer
Oncologie
Thérapie
Recherche
18.12.2014
document 1 document 2 document 3
niveau 1 niveau 2 niveau 3